Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
StocksRunnerFind out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends
01 Jul 2025$WOLF exploded 111% after announcing its pre-packaged restructuring plan, aiming to slash debt by 70% and shed $4.6 billion in liabilities. This move positions Wolfspeed to refocus on its long-term growth narrative and push toward profitability without the heavy debt drag. While bankruptcy headlines can scare off some traders, the massive volume and momentum behind WOLF show that many see the restructuring as a lifeline, not a death sentence, and are betting on the company emerging leaner and stronger.
$ATAI jumped 24% after announcing positive Phase 2b results for BPL-003 in treatment-resistant depression alongside a $50 million private placement. The data showed a significant reduction in depressive symptoms, sparking optimism around its psychedelic therapy pipeline and potential future market capture. The strong efficacy signals paired with fresh funding to advance development brought traders rushing in, pushing ATAI into the top gainers spotlight with a notable volume surge well above average.
$MESO climbed 11% after the FDA aligned with Mesoblast on the requirements for filing a Biologics License Application for Revascor, a cell therapy targeting heart failure. This alignment with regulators paves the way for a potential accelerated approval, fueling excitement around a long-awaited catalyst for Mesoblast’s pipeline.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
